Announcements
Trials
Browse
Landscape
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bile Duct Neoplasms
×
pembrolizumab
×
30 days
×
Clear all
Filters
3
NCT04924062
2026-04-15
KEYNOTE-966
Merck Sharp & Dohme LLC
Phase 3
Completed
158 enrolled
19 charts